<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is a significant interobserver and intraobserver variation in grading <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>New markers are needed to optimize the assessment of potential risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development in these patients </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study is to explore the use of p53 as a marker of <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Immunohistochemistry was used to study p53 protein accumulation in 114 specimens from 54 patients with Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Positive staining was found in 0% of the cases negative for <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 9% of those with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 55% of those with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 87% of those with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Follow-up was available on 24 patients </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients who showed low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and who were positive for p53 on biopsy showed high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in follow-up biopsies </plain></SENT>
<SENT sid="7" pm="."><plain>Of 21 patients who had biopsy specimens negative of p53, only one showed high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> on subsequent biopsy specimens </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our data support the hypothesis that p53 plays an important role in the progression of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>The follow-up study indicates that positive immunostaining for p53 may be an objective marker of <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
</text></document>